← Leaderboards
Gavin P. Robertson
Pennsylvania State Univ Hershey Med Ctr
$6,707,206
Attributed
$8,610,244
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,610,244 · 7
By mechanism
R01$8,314,157 · 4
R03$293,019 · 2
P41$3,068 · 1
Top collaborators
- Todd D Schell6 shared
- Shantu G Amin4 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Mark Kester$13,621,664
- Kevin Finnbar Staveleyo'carroll$5,239,458
- Todd D Schell$4,776,698
- W. Larry Kenney$10,723,575
- James R Connor$11,507,520
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaTumorBasePathway InteractionsAnimalsInnovationProteinsCell SurvivalSignal TransductionKillingsCancer CellSkin CancerLeadMelanoma CellMediatingNeoplasm MetastasisPreventCellsChemopreventive AgentMutantPharmaceutical PreparationsStagingPre-ClinicalMouse Model
Grant awards (26)
Targeting Aldehyde Dehydrogenase for Cancer Prevention$558,440
R01 · FY2024 · CA · contact PI
Targeting Aldehyde Dehydrogenase for Cancer Prevention$587,645
R01 · FY2023 · CA · contact PI
Targeting Aldehyde Dehydrogenase for Cancer Prevention$600,507
R01 · FY2022 · CA · contact PI
Targeting Aldehyde Dehydrogenase for Cancer Prevention$628,206
R01 · FY2021 · CA · contact PI
Targeting Aldehyde Dehydrogenase for Cancer Prevention$125,000
R01 · FY2021 · CA · contact PI
Targeting Aldehyde Dehydrogenase for Cancer Prevention$641,281
R01 · FY2020 · CA · contact PI
Targeted Chemoprevention for Melanoma$394,108
R01 · FY2014 · CA · contact PI
Synergistically Acting Targeted Therapeutics for Melanoma$302,813
R01 · FY2014 · CA · contact PI
Targeted Chemoprevention for Melanoma$382,639
R01 · FY2013 · CA · contact PI
Synergistically Acting Targeted Therapeutics for Melanoma$293,448
R01 · FY2013 · CA · contact PI
Targeted Chemoprevention for Melanoma$407,854
R01 · FY2012 · CA · contact PI
Synergistically Acting Targeted Therapeutics for Melanoma$312,178
R01 · FY2012 · CA · contact PI
Akt3 Signaling as a Therapeutic Target$303,925
R01 · FY2012 · CA · contact PI
Targeted Chemoprevention for Melanoma$432,123
R01 · FY2011 · CA · contact PI
Synergistically Acting Targeted Therapeutics for Melanoma$312,178
R01 · FY2011 · CA · contact PI
Akt3 Signaling as a Therapeutic Target$303,925
R01 · FY2011 · CA · contact PI
NMR IMAGING OF IRON OXIDE NANOPARTICLES$3,068
P41 · FY2011 · RR · contact PI
Targeted Chemoprevention for Melanoma$466,079
R01 · FY2010 · CA · contact PI
Synergistically Acting Targeted Therapeutics for Melanoma$321,833
R01 · FY2010 · CA · contact PI
Akt3 Signaling as a Therapeutic Target$313,325
R01 · FY2010 · CA · contact PI
Akt3 Signaling as a Therapeutic Target$313,325
R01 · FY2009 · CA · contact PI
Akt3 Signaling as a Therapeutic Target$313,325
R01 · FY2008 · CA · contact PI
Targeted Chemoprevention Through Inhibition of Akt3 Signaling$75,500
R03 · FY2008 · CA · contact PI
Targeted Chemoprevention Through Inhibition of Akt3 Signaling$75,500
R03 · FY2007 · CA · contact PI
Melanoma Chemoprevention by Targeting Mutant (V600E) B-Raf$69,947
R03 · FY2007 · CA · contact PI
Melanoma Chemoprevention by Targeting Mutant (V600E) B-Raf$72,072
R03 · FY2006 · CA · contact PI